🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
CMP
$CMPS
🔒 US EquitiesCOMPASS Pathways Plc – American
AVG HISTORICAL GAP
-0.61%
MAX GAP RECORD
-31.34%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $CMPS
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$CMPS
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 03, 2026 Earnings Release 2026-11-03 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 05, 2026 Earnings Release 2026-08-05 (BEFORE OPEN) |
-1.69%
|
| May 13, 2026 Earnings Release 2026-05-13 (BEFORE OPEN) |
+5.12%
|
| Mar 24, 2026 Earnings Release 2026-03-24 (BEFORE OPEN) |
-0.75%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (BEFORE OPEN) |
+9.58%
|
| Jul 31, 2025 Earnings Release 2025-07-31 (BEFORE OPEN) |
+2.03%
|
| May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN) |
+1.37%
|
| Feb 27, 2025 Earnings Release 2025-02-27 (BEFORE OPEN) |
+15.30%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.5%
Bullish Gaps (8)
Bearish Gaps (6)
Neutral / Flat (1)
📖 Intelligence Summary
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗